This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

RGX-121

Regenxbio Inc.

Drug Names(s): NAV AAV Vectors, rAAV9

Description: RGX-121 uses the AAV9 vector to deliver the human IDS gene to the CNS.


RGX-121 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug